Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 1 1

Status

Completed 4Recruiting 3Unknown 1Active not recruiting 1

Sponsor Class

OTHER 9

Study Type

Interventional 6Observational 3

Sponsor

Cancer Type

Gynecologic 3Genitourinary 3Thoracic 2Plasma cell 1Breast 1

Conditions

Breast Neoplasms 118Neoplasms 110Lung Neoplasms 65Colorectal Neoplasms 52Prostatic Neoplasms 46Carcinoma, Non-Small-Cell Lung 46Pancreatic Neoplasms 34Melanoma 33Ovarian Neoplasms 29Neoplastic Cells, Circulating 29Head and Neck Neoplasms 27Uterine Cervical Neoplasms 23Multiple Myeloma 20Glioma 20Colonic Neoplasms 20Sarcoma 19Carcinoma, Hepatocellular 19Leukemia, Myeloid, Acute 18Neoplasm Metastasis 17Lymphoma 15Glioblastoma 15Esophageal Neoplasms 15Squamous Cell Carcinoma of Head and Neck 14Hematologic Neoplasms 14Leukemia 13Endometrial Neoplasms 13Myelodysplastic Syndromes 11Kidney Neoplasms 11Gastrointestinal Neoplasms 11Carcinoma, Renal Cell 11

Interventions

Blood Specimen Collection 9Surveys and Questionnaires 6Magnetic Resonance Spectroscopy 6Dexamethasone 6Cyclophosphamide 6Prednisone 5Mammography 5Colonoscopy 5Biopsy 5Positron Emission Tomography Computed Tomography 4Magnetic Resonance Imaging 4Lenalidomide 4Biopsy, Fine-Needle 4pembrolizumab 3Tomography, X-Ray Computed 3Surgical Procedures, Operative 3Melphalan 3Liquid Biopsy 3Interviews as Topic 3Exercise 3Diagnostic Tests, Routine 32-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3weifuchun 2obinutuzumab 2fluciclovine F-18 2daratumumab 2carfilzomib 2Urination 2Preoperative Exercise 2Positron-Emission Tomography 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

9 trials
RecentStart dateEnrollment
Disease × Blood Specimen Collection × Clear all
NCT07054346 2026-04-01

LUTACT

University of California, San Francisco

Phase 1 Recruiting
45 enrolled
Genitourinary

Disease, Prostatic Neoplasms

NCT07465848 2026-03-12

PneumoTAV001

Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)

Phase NA Recruiting
1,200 enrolled
Thoracic

Disease, Lung Neoplasms

NCT05141383 2025-09-08

HOPE

Institut Curie

Phase NA Completed
80 enrolled
Genitourinary

Disease, Prostatic Neoplasms

NCT03776630 2025-08-12

GYNO-MIR

Assistance Publique - Hôpitaux de Paris

Phase NA Active not recruiting
363 enrolled
Gynecologic

Disease, Ovarian Neoplasms, Endometrial Neoplasms

NCT05151341 2025-07-24

URODX-FGFR3

Institut de Cancérologie de Lorraine

Phase NA Completed
190 enrolled
Genitourinary

Urinary Bladder Neoplasms, Disease, Neoplasms

NCT02662621 2025-06-05

EXODIAG

Centre Georges Francois Leclerc

Phase NA Completed
71 enrolled
BreastGynecologicThoracic

Breast Neoplasms, Disease, Lung Neoplasms, Neoplasms, Ovarian Neoplasms

NCT06355245 2024-04-09

MEDECA

Danderyd Hospital

Recruiting
1,500 enrolled

Disease, Neoplasms

NCT03553589 2018-12-05

BioEndoCar

Academisch Ziekenhuis Maastricht

Unknown
400 enrolled
Gynecologic

Disease, Endometrial Neoplasms

NCT00639054 2016-01-07

MM-FISH/DNA

Rigshospitalet, Denmark

Completed
134 enrolled
Plasma cell

Disease, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡